The presence of isoform 3, which contains S3 and S1 cleavage sites (see Figure S1), together with the inactivation of OMA1 protease (see also [32]), could explain the shift of electrophoretic mobility observed in MS patients. The gene discussed is OMA1; the disease is myeloid sarcoma.